Willem Scholten Consultancy

Tweet this page
<
2016
2017
2018
2019
>
No longer registered as of 26 Feb 2020 - Registration as it was on 04 Nov 2019
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

17,500€

Financial year: Jan 2018 - Dec 2018

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Willem Scholten Consultancy

    EU Transparency Register

    255298920864-73 First registered on 01 Mar 2016

    Goals / Remit

    Consultant - Medicines and Controlled Substances, i.e. independent consultant in the area of improving access to controlled medicines and (psychoactive) substance control policies.

    Main EU files targeted

    Policies of the EU Hortizontal Drugs Group with regards to EU position taken in the UN Commission on Narcotic Drugs en WHO, in particular the ECDD; Commenting on drug control policies by publishing and presenting at conferences, e.g. the EU focused annual SIP conference;
    Researching and promoting access to controlled medicines globally; Former Expert Member of a guidelines group of the CoE Pompidou Group developing Guiding Principles for Legislation and Regulations on Opioid Agonist Treatment.

    Address

    Head Office
    Wielsekade 64
    Lopik 3411AD
    NETHERLANDS
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Willem Scholten (owner)

    Person with legal responsibility

    Mr Willem Scholten (owner)

  • Categories

    Category

    I - Professional consultancies/law firms/self-employed consultants

    Subcategory

    Self-employed consultants

  • Networking

    Affiliation

    Koninklijke Nederlandse Maatschappij ter Bevordering van de Pharmacie (KNMP)
    International Association for Hospice and Palliative Care (IAHPC)

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2018 - Dec 2018

    Lobbying costs for closed financial year

    17,500€

    Other financial info

    None declared

    Declared lobby clients

    Client Name Amount
    BC Eurocenter SA 0€ - 9,999€
    CannNext BV/Stipgo BV 0€ - 9,999€
    Grünenthal GmBH (Germany) and Grünenthal BV (Netherlands) 25,000€ - 49,999€
    Jazz Pharmaceuticals 0€ - 9,999€
  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    Regular speaker at conferences on issues like access to opioid analgesics, and on problems with non-medical use of psychoactive substances, including the Societal Impact of Pain conference, usually held with sponsorship of MEPs.
    Medical writer for pharmaceutical companies.
    See Google Scholar Citations for publications.

    Other activities

    Former Expert Member for WHO of the Pompidou Group Expert Committee on legislation on access to treatment of opioid dependence (TDOLEG)
    Participated in the Workshop ‘Towards transatlantic co-operation in pain research’, organised by the European Commission (29 October 2018)

  • Meetings

    Meetings

    None declared

Download this datacard